×
Prescription Required

AMLODAC-T TAB


Rs 227.15 10 % Off


Package size

  • Rs 227.15
  • 15 Soft gelatin Capsules

    Estimate Delivery by: Tomorrow

    Delivering to 201301, Noida


    Easy 7 days return available

    Rs 227.15 10 % Off

    AMLODAC-T TAB

    Amlodac T Tablet is a combination medication used to manage hypertension by combining Amlodipine and Telmisartan. Amlodipine, a calcium channel blocker, relaxes blood vessels, while Telmisartan, an angiotensin-II receptor blocker, reduces heart strain by blocking the effects of angiotensin-II. This combination effectively lowers blood pressure. Common side effects include dizziness, headache, low blood pressure, swollen ankles, and fatigue. This medication is not suitable for individuals with severe heart, liver, or kidney conditions and should be used with caution in elderly patients and those who are pregnant or breastfeeding. Always follow the prescribed dosage and administration instructions from your healthcare provider.

    Product Highlights and Usage:

    Antihypertensive Combination: Contains Amlodipine (5 mg) and Telmisartan (40 mg) for managing high blood pressure. Mechanism of Action: Amlodipine relaxes blood vessels; Telmisartan blocks angiotensin-II receptors, reducing strain on the heart. Side Effects: Common side effects include dizziness, headache, low blood pressure, swollen ankles, and fatigue. Usage Precautions: Not recommended for patients with severe heart, liver, or kidney conditions. Caution in elderly and pregnant or breastfeeding women. Administration: Should be taken as prescribed by a healthcare provider, with or without food.

    4.2
    Date

    Super Admin

    Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s

    medicare-logo-white

    APMEDCARE: Your digital partner in navigating secure, accessible healthcare services.

    Recent Posts

    Our services

    Copyright @ AXOLAB PHARMACEUTICALS PRIVATE LIMITED, 2025. All rights reserved.